VERU-111, an novel oral α and β tubulin inhibitor, has potent activity against paclitaxel sensitive and resistant prostate cancer
European Urology Supplements（2018）
关键词
tubulin inhibitor,prostate cancer,paclitaxel
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要